Enterobacteriaceae Infections
Information
- Disease name
- Enterobacteriaceae Infections
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05055479 | Completed | Nosocomial Outbreak of BHRe in an Intensive Care Unit During SARS-CoV-2 Pandemic | August 1, 2021 | February 1, 2022 | |
| NCT00573235 | Completed | Epidemiology of Community - Associated Extended-spectrum Beta-lactamases (ESBL) Producing Escherichia Coli | October 2007 | June 2017 | |
| NCT00573521 | Completed | Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum Beta-Lactamase (ESBL) Producing Organisms | November 2007 | June 2017 | |
| NCT00826670 | Completed | Phase 4 | Enterobacteriaceae Producing Extended-spectrum β-lactamases (ESBL) Decolonization Study | June 2009 | August 2012 |
| NCT04528043 | Completed | Infections and Colonization With the Third Group of Enterobacteriaceae in the Intensive Care Unit | April 1, 2017 | December 31, 2019 | |
| NCT01725841 | Completed | The Prevalence of Extend-Spectrum β-Lactamase (ESBL) Producing Isolates Among Common Enterobacteriaceae in Taiwan | April 2009 | September 2009 | |
| NCT02400268 | Completed | Phase 3 | Antibiotic Treatment Duration (7 vs 14 Days) Comparison in Blood Stream Infection Causes by Enterobacteriaceae | September 2014 | March 1, 2017 |
| NCT03477084 | Completed | Understanding and Modeling Reservoirs, Vehicles and Transmission of ESBL-producing Enterobacteriaceae in the Community and Long Term Care Facilities | March 1, 2017 | February 29, 2020 | |
| NCT02482051 | Completed | Ultra Rapid Culture Independent Detection of High-Priority Carbapenem Resistant Enterobacteriaceae Directly From Blood | July 2015 | January 31, 2022 | |
| NCT02795949 | Completed | Phase 3 | Study on Reduced Antibiotic Treatment vs Broad Spectrum Betalactam in Patients With Bacteremia by Enterobacteriaceae | October 2016 | January 2020 |
| NCT03401242 | Completed | Prevalence of ESBL and CPE in French Nursing Homes | October 3, 2018 | January 14, 2019 | |
| NCT03924934 | Enrolling by invitation | Community-associated Highly-Resistant Enterobacterales | May 1, 2019 | December 2024 | |
| NCT05632315 | Not yet recruiting | Phase 2 | PMT for MDRO Decolonization | June 2024 | January 2026 |
| NCT05791396 | Not yet recruiting | Phase 1/Phase 2 | FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae | April 2023 | April 2026 |
| NCT03671967 | Recruiting | Phase 4 | PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN) | May 1, 2019 | April 2026 |
| NCT04276480 | Recruiting | N/A | Efficacy of Piperacillin-tazobactam as Empirical Antimicrobial Therapy for VAP Among ESBL-E Carriers. | February 16, 2022 | August 2024 |
| NCT04836208 | Recruiting | Neonatal Acquisition of ESBL-PE in a Low-income Country - NeoLIC | April 30, 2021 | May 2023 | |
| NCT05035342 | Recruiting | Phase 3 | Fecal Transplantation to Eradicate Colonizing Emergent Superbugs | January 11, 2024 | April 2028 |
| NCT05516433 | Recruiting | Effect of Imipenem and Meropenem on the Digestive Microbiota and the Emergence and Carriage of Multidrug-resistant Bacteria | January 23, 2023 | December 31, 2025 | |
| NCT05355350 | Suspended | Phase 4 | PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream Infections | July 1, 2022 | April 15, 2028 |
| NCT04759001 | Unknown status | Phase 1/Phase 2 | FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae | February 18, 2021 | February 18, 2023 |
| NCT00894036 | Unknown status | The Burden and Genetic Variability of Extended-Spectrum ß-Lactamase (ESBL) - Producing Pathogens in Swiss Children | July 2008 | December 2010 | |
| NCT04903886 | Unknown status | Intensive Care Unit Acquired Infections in Patients Colonized With Extended Spectrum Enterobacteriaceae | June 1, 2021 | December 1, 2021 | |
| NCT02450942 | Unknown status | Early Phase 1 | 18F-FDS PET/CT in Healthy Volunteers and Patients With Suspected Infection | January 2015 | March 2018 |
| NCT03891433 | Unknown status | Phase 4 | Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing Enterobacteriaceae | April 1, 2019 | April 1, 2021 |
| NCT00404625 | Unknown status | Infections Caused by ESbL-Producing Enterobacteriaceae in Italy | October 2006 | November 2006 | |
| NCT03967301 | Unknown status | N/A | Prevention and Decolonization of Multidrug-resistant Bacteria With Probiotics | October 2019 | December 2019 |
| NCT03411590 | Unknown status | N/A | The Effect of Fortified Growing-up Milk on Growth and Micronutrient Status of Nigerian Toddlers | February 5, 2018 | January 24, 2019 |
| NCT03527056 | Withdrawn | Early Phase 1 | Pilot Study Using Oral Capsule FMT to Decolonize GI CRE | June 2019 | September 24, 2019 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D004756